IP Library Granted Patent US 8,277,829
Granted Patent B2
US 8,277,829 · App. 12/377,699 · Granted Oct 2, 2012

Nano/macroporous bone tissue scaffolds for regenerative medicine

Assignee: Lehigh University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,277,829
App. No.
12/377,699
Granted
Oct 2, 2012
Kind
B2
Abstract

A biocompatible inorganic porous material having a three-dimensional coexistent network of interconnected macro-pores and nanopores produced by the steps of mixing an organic water-soluble polymer (e.g., polyethylene oxide or a block copolymer of ethylene oxide and propylene oxide), an alkoxysilane, and an inorganic water-soluble calcium salt in an aqueous acid solution, such that a sol-gel process of hydrolysis and polycondensation is initiated and thereby producing a gel; drying the gel to remove solvent by evaporation; and heating the gel to remove the polymer by thermal decomposition, thereby forming an inorganic porous material, which may be suitable for use as a bone tissue scaffold.

Claims (29)

1. A method for producing a biocompatible inorganic porous material having a three-dimensional network of coexistent interconnected macropores and nanopores, which method comprises steps of:

mixing an organic water-soluble polymer, an alkoxysilane, and an inorganic water-soluble calcium salt in an aqueous acid solution, such that a sol-gel process of hydrolysis and polycondensation is initiated and thereby producing a gel;

drying said gel to remove solvent by evaporation; and

heating said gel to remove said polymer by thermal decomposition, thereby forming an inorganic porous bioactive material, that is characterized by interconnected multimodal porosity including nanopores of about 5 to about 40 nm in size, macropores from about 1 μm to about 300 μm in size, corresponding to a volume fraction of porosity between about 38 to about 67 percent, as determined by a porisimetry method selected from the group consisting of mercury intrusion porisimetry and nitrogen adsorption porisimetry.

2. The method according to claim 1 , wherein said drying step produces the nanopores, and said heating step produces the macropores.

3. The method according to claim 2 , wherein the step of mixing is performed without foaming.

4. The method according to claim 1 , further comprising a step of aging said gel at a temperature of about 40° C.

5. The method according to claim 1 , wherein said drying step occurs at a temperature of from about 40° C. to about 180° C.

6. The method according to claim 1 , wherein said heating step occurs at a temperature of greater than about 600° C.

7. The method according to claim 1 , further comprising a step of immersing said gel into an aqueous ammonia solution, such that solvent exchange occurs.

8. The method according to claim 1 , wherein said alkoxysilane is selected from the group consisting of tetramethoxysilane, tetraethoxysilane, methyltriethoxysilane, (3-glycidoxypropyl)trimethoxysilane, and combinations thereof.

9. The method according to claim 1 , wherein said inorganic water-soluble calcium salt is selected from the group consisting of calcium nitrate and hydrates thereof.

10. The method according to claim 1 , wherein said organic water-soluble polymer is selected from the group consisting of polymers of ethylene oxide, polymers of propylene oxide, polymers of ethylene glycol, copolymers of ethylene oxide and propylene oxide, and mixtures thereof.

11. The method according to claim 1 , wherein said organic water-soluble polymer is polyethylene oxide or a block copolymer of ethylene oxide and propylene oxide.

12. The method according to claim 1 , wherein said aqueous acid solution further comprises a trialkyl orthophosphate.

13. The method according to claim 12 , wherein said trialkyl orthophosphate is triethyl orthophosphate.

14. The method according to claim 1 , wherein said aqueous acid solution further comprises a water-soluble zinc salt.

15. The method according to claim 14 , wherein said water-soluble zinc salt is zinc nitrate.

16. The method according to claim 1 , wherein said aqueous acid solution further comprises a pore expander additive.

17. The method according to claim 16 , wherein said pore expander additive is urea or 1,3,5-trimethylbenzene.

18. The method according to claim 1 , wherein said aqueous acid solution comprises an acid selected from the group consisting of hydrofluoric acid, nitric acid, acetic acid, and combinations thereof.

19. A biocompatible inorganic porous material having a three-dimensional network of coexistent interconnected macropores and nanopores produced by the steps of:

mixing an organic water-soluble polymer, an alkoxysilane, and an inorganic water-Soluble calcium salt in an aqueous acid solution, such that a sol-gel process of hydrolysis and polycondensation is initiated and thereby producing a gel;

drying said gel to remove solvent by evaporation; and

heating said gel to remove said polymer by thermal decomposition, thereby forming an inorganic porous bioactive material, wherein the material is characterized by interconnected multimodal porosity including nanopores of about 5 to about 40 nm in size, macropores from about 1 μm to about 300 μm in size, corresponding to a volume fraction of porosity between about 38 to about 67 percent, as determined by a porisimetry method selected from the group consisting of mercury intrusion porisimetry and nitrogen adsorption porisimetry.

20. The material according to claim 19 , wherein said inorganic porous material has a phosphorous:calcium molar ratio of from about 0.0 to about 0.6.

21. The material according to claim 19 , wherein said inorganic porous material has a zinc:calcium molar ratio of from about 0.0 to about 0.3.

22. A method of inducing bone growth or regeneration in a mammal comprising a step of implanting a biocompatible inorganic porous material according to claim 19 in a mammal in need thereof, such that hydroxycarbonate apatite growth occurs on an interior or exterior surface of said biocompatible inorganic porous material.

23. A method of stimulating cell growth or differentiation comprising a step of placing one or more cells onto a surface of a biocompatible inorganic porous material according to claim 19 .

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 23, 2015
From: LEHIGH UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 036163/0452 →
CONFIRMATORY LICENSE Recorded May 18, 2011
From: LEHIGH UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 026304/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2009
From: JAIN, HIMANSHU; MARQUES, ANA C.; ALMEIDA, RUI M.
To: LEHIGH UNIVERSITY
Reel/Frame 022264/0027 →
Continuity (2)
Provisional Application 60824161 · Aug 31, 2006
Related Publication 20100272826A1 · Oct 28, 2010